Related references
Note: Only part of the references are listed.Anemia is a risk factor for rapid eGFR decline in type 2 diabetes
Lijie Xie et al.
FRONTIERS IN ENDOCRINOLOGY (2023)
Prevalence and risk factors of chronic kidney disease among patients with type 2 diabetes mellitus at a tertiary care hospital in Nepal: a cross-sectional study
Rinku Joshi et al.
BMJ OPEN (2023)
Glycemic Targets: Standards of Care in Diabetes-2023
Nuha A. ElSayed et al.
DIABETES CARE (2023)
Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023
Nuha A. ElSayed et al.
DIABETES CARE (2023)
Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023
Nuha A. ElSayed et al.
DIABETES CARE (2023)
Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
Gyorgy Herczeg et al.
OPEN MEDICINE (2022)
Increasing Incidence of Early-Onset Colorectal Cancer
Frank A. Sinicrope
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019
Jinchi Xie et al.
BMJ-BRITISH MEDICAL JOURNAL (2022)
The Role of Tumor Microenvironment and Immune Response in Colorectal Cancer Development and Prognosis
Maria Wozniakova et al.
PATHOLOGY & ONCOLOGY RESEARCH (2022)
Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis
Fausto Petrelli et al.
CANADIAN JOURNAL OF DIABETES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Preexisting Type 2 Diabetes and Survival among Patients with Colorectal Cancer
Chen Yuan et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Impact of diabetes on colorectal cancer stage and mortality risk: a population-based cohort study
Judy K. Qiang et al.
DIABETOLOGIA (2020)
Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study
Huan Tao et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
G. Argiles et al.
ANNALS OF ONCOLOGY (2020)
Diabetes mellitus and colorectal carcinoma outcomes: a meta-analysis
Daniel J. Becker et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)
Renal function deterioration in adult patients with type-2 diabetes
Peter Bramlage et al.
BMC NEPHROLOGY (2020)
Type 2 Diabetes and its Impact on the Immune System
Afiat Berbudi et al.
CURRENT DIABETES REVIEWS (2020)
Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk
Sander de Kort et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten et al.
IMMUNITY (2019)
Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes
Jetty A. Overbeek et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
Physical activity, obesity and sedentary behaviour and the risks of colon and rectal cancers in the 45 and up study
Carlos Nunez et al.
BMC PUBLIC HEALTH (2018)
Type 2 diabetes and colorectal cancer survival: The multiethnic cohort
Yvette Amshoff et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature
Burcin Baran et al.
GASTROENTEROLOGY RESEARCH (2018)
Comparison of MDRD, CKD-EPI, and Cockcroft-Gault equation in relation to measured glomerular filtration rate among a large cohort with diabetes
Anke Schwandt et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis
Jingtao Li et al.
ONCOTARGET (2017)
2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
Nieves Gonzalez et al.
ONCOTARGET (2017)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2017)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy
Gadi Shlomai et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Type 2 diabetes mellitus
Ralph A. DeFronzo et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues
Anders Lundby et al.
JOURNAL OF APPLIED TOXICOLOGY (2015)
Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study
M. M. J. Zanders et al.
DIABETIC MEDICINE (2013)
Adherence to Therapies in Patients with Type 2 Diabetes
Luis-Emilio Garcia-Perez et al.
DIABETES THERAPY (2013)
HDL dysfunction in diabetes: causes and possible treatments
Dan Farbstein et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2012)
The effects of age and comorbidity on treatment patterns for radiotherapy and survival in patients with mobile rectal cancer: A population-based study
H. A. A. M. Maas et al.
EUROPEAN GERIATRIC MEDICINE (2011)
Hypoglycemia, Diabetes, and Cardiovascular Events
Cyrus V. Desouza et al.
DIABETES CARE (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Defining and Characterizing the Progression of Type 2 Diabetes
Vivian A. Fonseca
DIABETES CARE (2009)
Missing data methods in longitudinal studies: a review
Joseph G. Ibrahim et al.
TEST (2009)
The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer
Cary P. Gross et al.
CANCER (2007)
Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer
VEPP Lemmens et al.
BRITISH JOURNAL OF SURGERY (2005)